Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Innovations Inc Pyxis currently holds 6,884,057 shares of INTERLEUKIN GENETICS INC (ILI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Innovations Inc Pyxis has been a net neutral trader of ILI stock. They have purchased $0 and sold $0 worth of shares.
Innovations Inc Pyxis's most recent insider trade was on Jun 11, 2008, when they sold 943,032 shares at $0.64 per share.
Innovations Inc Pyxis serves as Executive at INTERLEUKIN GENETICS INC (ILI). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Innovations Inc Pyxis holds the position of Executive at INTERLEUKIN GENETICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Innovations Inc Pyxis has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Innovations Inc Pyxis was on Dec 17, 2007, when they sold $2.0M worth of ILI shares. This transaction involved 3,190,988 shares at $0.64 per share.
Innovations Inc Pyxis currently owns 6,884,057 shares of INTERLEUKIN GENETICS INC (ILI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Innovations Inc Pyxis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Innovations Inc Pyxis has 2 Form 4 filings on record as an insider at INTERLEUKIN GENETICS INC.
Set alerts for Innovations Inc Pyxis and 40,000+ other insiders.